BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 20001622)

  • 1. Heart disease in thalassemia intermedia.
    Aessopos A; Tsironi M; Andreopoulos A; Farmakis D
    Hemoglobin; 2009; 33 Suppl 1():S170-6. PubMed ID: 20001622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Congestive heart failure and treatment in thalassemia major.
    Aessopos A; Kati M; Tsironi M
    Hemoglobin; 2008; 32(1-2):63-73. PubMed ID: 18274984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heart disease in thalassemia intermedia: a review of the underlying pathophysiology.
    Aessopos A; Kati M; Farmakis D
    Haematologica; 2007 May; 92(5):658-65. PubMed ID: 17488690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heart failure in beta-thalassemia syndromes: a decade of progress.
    Hahalis G; Alexopoulos D; Kremastinos DT; Zoumbos NC
    Am J Med; 2005 Sep; 118(9):957-67. PubMed ID: 16164878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thalassemia intermedia is associated with a proatherogenic biochemical phenotype.
    Lai ME; Vacquer S; Carta MP; Spiga A; Cocco P; Angius F; Mandas A; Dessì S
    Blood Cells Mol Dis; 2011 Apr; 46(4):294-9. PubMed ID: 21402483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pulmonary hypertension in beta-thalassemia.
    Aessopos A; Farmakis D
    Ann N Y Acad Sci; 2005; 1054():342-9. PubMed ID: 16339682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beta-thalassemia cardiomyopathy: history, present considerations, and future perspectives.
    Kremastinos DT; Farmakis D; Aessopos A; Hahalis G; Hamodraka E; Tsiapras D; Keren A
    Circ Heart Fail; 2010 May; 3(3):451-8. PubMed ID: 20484195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thalassemia heart disease: a comparative evaluation of thalassemia major and thalassemia intermedia.
    Aessopos A; Farmakis D; Deftereos S; Tsironi M; Tassiopoulos S; Moyssakis I; Karagiorga M
    Chest; 2005 May; 127(5):1523-30. PubMed ID: 15888823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of the cardiovascular complications of thalassemia by echocardiography.
    Walker JM; Nair S
    Ann N Y Acad Sci; 2010 Aug; 1202():165-72. PubMed ID: 20712789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Guideline recommendations for heart complications in thalassemia major.
    Cogliandro T; Derchi G; Mancuso L; Mayer MC; Pannone B; Pepe A; Pili M; Bina P; Cianciulli P; De Sanctis V; Maggio A;
    J Cardiovasc Med (Hagerstown); 2008 May; 9(5):515-25. PubMed ID: 18404006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insight onto the pathophysiology and clinical complications of thalassemia intermedia.
    Cappellini MD; Musallam KM; Taher AT
    Hemoglobin; 2009; 33 Suppl 1():S145-59. PubMed ID: 20001620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinicopathological and radiological study of Egyptian β-thalassemia intermedia and β-thalassemia major patients: relation to complications and response to therapy.
    Mokhtar GM; Tantawy AA; Adly AA; Ismail EA
    Hemoglobin; 2011; 35(4):382-405. PubMed ID: 21797705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Histological picture of liver disease in thalassemia intermedia].
    Mancosu MG; Galanello R; Ambu R; De Virgiliis S; Giagu N; Cao A; Faa G
    Pathologica; 2000 Aug; 92(4):241-8. PubMed ID: 11029884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular effects of splenomegaly and splenectomy in beta-thalassemia.
    Aessopos A; Farmakis D; Deftereos S; Tsironi M; Polonifi A; Moyssakis I; Diamanti-Kandaraki E; Papalambros E
    Ann Hematol; 2005 Jun; 84(6):353-7. PubMed ID: 15711802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MRI of cardiac iron overload.
    Chu WC; Au WY; Lam WW
    J Magn Reson Imaging; 2012 Nov; 36(5):1052-9. PubMed ID: 23090916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiac involvement in sickle beta-thalassemia.
    Aessopos A; Farmakis D; Trompoukis C; Tsironi M; Moyssakis I; Tsaftarides P; Karagiorga M
    Ann Hematol; 2009 Jun; 88(6):557-64. PubMed ID: 19107483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of beta globin gene mutations on the clinical phenotype of beta thalassemia in India.
    Colah R; Nadkarni A; Gorakshakar A; Phanasgaonkar S; Surve R; Subramaniam PG; Bondge N; Pujari K; Ghosh K; Mohanty D
    Blood Cells Mol Dis; 2004; 33(2):153-7. PubMed ID: 15315795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic modifiers of beta-thalassemia.
    Thein SL
    Haematologica; 2005 May; 90(5):649-60. PubMed ID: 15921380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular, hematological and clinical aspects of thalassemia major and thalassemia intermedia associated with Hb E-beta-thalassemia in Northeast Thailand.
    Nuntakarn L; Fucharoen S; Fucharoen G; Sanchaisuriya K; Jetsrisuparb A; Wiangnon S
    Blood Cells Mol Dis; 2009; 42(1):32-5. PubMed ID: 18951049
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beta-thalassemia and pulmonary function.
    Piatti G; Allegra L; Ambrosetti U; Cappellini MD; Turati F; Fiorelli G
    Haematologica; 1999 Sep; 84(9):804-8. PubMed ID: 10477453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.